nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ALB—ulcerative colitis	0.15	0.512	CbGaD
Gefitinib—ABCB1—ulcerative colitis	0.143	0.488	CbGaD
Gefitinib—CYP1A1—Nicotine—ulcerative colitis	0.0336	0.0795	CbGbCtD
Gefitinib—CYP1A1—Cholecalciferol—ulcerative colitis	0.0301	0.0713	CbGbCtD
Gefitinib—ABCG2—Sulfasalazine—ulcerative colitis	0.0283	0.067	CbGbCtD
Gefitinib—ABCG2—Hydrocortisone—ulcerative colitis	0.0227	0.0537	CbGbCtD
Gefitinib—CYP3A4—Budesonide—ulcerative colitis	0.0181	0.0427	CbGbCtD
Gefitinib—CYP2C19—Nicotine—ulcerative colitis	0.0163	0.0385	CbGbCtD
Gefitinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.0157	0.0371	CbGbCtD
Gefitinib—ALB—Prednisone—ulcerative colitis	0.0156	0.0369	CbGbCtD
Gefitinib—CYP2C19—Cholecalciferol—ulcerative colitis	0.0146	0.0345	CbGbCtD
Gefitinib—ABCG2—Dexamethasone—ulcerative colitis	0.0141	0.0334	CbGbCtD
Gefitinib—CYP2C9—Nicotine—ulcerative colitis	0.0135	0.032	CbGbCtD
Gefitinib—ABCB1—Methylprednisolone—ulcerative colitis	0.0135	0.0319	CbGbCtD
Gefitinib—CYP1A1—Dexamethasone—ulcerative colitis	0.013	0.0308	CbGbCtD
Gefitinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.0126	0.0298	CbGbCtD
Gefitinib—CYP2D6—Nicotine—ulcerative colitis	0.0124	0.0292	CbGbCtD
Gefitinib—CYP2C9—Cholecalciferol—ulcerative colitis	0.0121	0.0287	CbGbCtD
Gefitinib—CYP2D6—Cholecalciferol—ulcerative colitis	0.0111	0.0262	CbGbCtD
Gefitinib—CYP2C19—Prednisone—ulcerative colitis	0.0101	0.0239	CbGbCtD
Gefitinib—ABCB1—Betamethasone—ulcerative colitis	0.00875	0.0207	CbGbCtD
Gefitinib—ABCB1—Prednisolone—ulcerative colitis	0.00863	0.0204	CbGbCtD
Gefitinib—ABCB1—Hydrocortisone—ulcerative colitis	0.00819	0.0194	CbGbCtD
Gefitinib—ABCB1—Prednisone—ulcerative colitis	0.00815	0.0193	CbGbCtD
Gefitinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00806	0.0191	CbGbCtD
Gefitinib—CYP3A4—Nicotine—ulcerative colitis	0.00786	0.0186	CbGbCtD
Gefitinib—CYP3A5—Dexamethasone—ulcerative colitis	0.00782	0.0185	CbGbCtD
Gefitinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00705	0.0167	CbGbCtD
Gefitinib—CYP2C19—Dexamethasone—ulcerative colitis	0.00631	0.0149	CbGbCtD
Gefitinib—CYP3A4—Triamcinolone—ulcerative colitis	0.00611	0.0145	CbGbCtD
Gefitinib—ORM1—bile—ulcerative colitis	0.0055	0.165	CbGeAlD
Gefitinib—CYP2C9—Dexamethasone—ulcerative colitis	0.00525	0.0124	CbGbCtD
Gefitinib—CYP3A4—Betamethasone—ulcerative colitis	0.00524	0.0124	CbGbCtD
Gefitinib—CYP3A4—Prednisolone—ulcerative colitis	0.00517	0.0122	CbGbCtD
Gefitinib—ABCB1—Dexamethasone—ulcerative colitis	0.00509	0.012	CbGbCtD
Gefitinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.0049	0.0116	CbGbCtD
Gefitinib—CYP3A4—Prednisone—ulcerative colitis	0.00489	0.0116	CbGbCtD
Gefitinib—CYP2D6—Dexamethasone—ulcerative colitis	0.0048	0.0114	CbGbCtD
Gefitinib—CYP3A4—Dexamethasone—ulcerative colitis	0.00305	0.00722	CbGbCtD
Gefitinib—Vandetanib—RIPK2—ulcerative colitis	0.00217	0.529	CrCbGaD
Gefitinib—ERBB3—epithelium—ulcerative colitis	0.00141	0.0423	CbGeAlD
Gefitinib—MKNK2—epithelium—ulcerative colitis	0.00134	0.0402	CbGeAlD
Gefitinib—MKNK2—smooth muscle tissue—ulcerative colitis	0.00129	0.0387	CbGeAlD
Gefitinib—IRAK1—smooth muscle tissue—ulcerative colitis	0.00129	0.0387	CbGeAlD
Gefitinib—CSNK1E—digestive system—ulcerative colitis	0.00111	0.0333	CbGeAlD
Gefitinib—IRAK4—lymphoid tissue—ulcerative colitis	0.00111	0.0332	CbGeAlD
Gefitinib—ERBB3—lymphoid tissue—ulcerative colitis	0.00108	0.0326	CbGeAlD
Gefitinib—ERBB3—digestive system—ulcerative colitis	0.00107	0.0322	CbGeAlD
Gefitinib—MKNK2—lymphoid tissue—ulcerative colitis	0.00103	0.031	CbGeAlD
Gefitinib—MKNK2—digestive system—ulcerative colitis	0.00102	0.0306	CbGeAlD
Gefitinib—MKNK1—lymphoid tissue—ulcerative colitis	0.00102	0.0306	CbGeAlD
Gefitinib—MKNK1—digestive system—ulcerative colitis	0.00101	0.0302	CbGeAlD
Gefitinib—EGFR—liver—ulcerative colitis	0.00086	0.0258	CbGeAlD
Gefitinib—STK10—lymphoid tissue—ulcerative colitis	0.000838	0.0252	CbGeAlD
Gefitinib—STK10—digestive system—ulcerative colitis	0.000828	0.0249	CbGeAlD
Gefitinib—CSNK1E—liver—ulcerative colitis	0.000827	0.0248	CbGeAlD
Gefitinib—IRAK4—liver—ulcerative colitis	0.000814	0.0244	CbGeAlD
Gefitinib—ERBB3—liver—ulcerative colitis	0.000798	0.024	CbGeAlD
Gefitinib—MKNK2—liver—ulcerative colitis	0.000759	0.0228	CbGeAlD
Gefitinib—IRAK1—liver—ulcerative colitis	0.000759	0.0228	CbGeAlD
Gefitinib—MKNK1—liver—ulcerative colitis	0.000749	0.0225	CbGeAlD
Gefitinib—ERBB3—Methyldopa—Mesalazine—ulcerative colitis	0.000668	0.176	CbGdCrCtD
Gefitinib—STK10—liver—ulcerative colitis	0.000617	0.0185	CbGeAlD
Gefitinib—Lapatinib—ABCB1—ulcerative colitis	0.00057	0.139	CrCbGaD
Gefitinib—MAP2K5—liver—ulcerative colitis	0.000551	0.0165	CbGeAlD
Gefitinib—CYP1A1—epithelium—ulcerative colitis	0.000449	0.0135	CbGeAlD
Gefitinib—ORM1—liver—ulcerative colitis	0.000447	0.0134	CbGeAlD
Gefitinib—CYP2C19—digestive system—ulcerative colitis	0.000424	0.0127	CbGeAlD
Gefitinib—Afatinib—ABCB1—ulcerative colitis	0.000404	0.0985	CrCbGaD
Gefitinib—ALB—liver—ulcerative colitis	0.000392	0.0118	CbGeAlD
Gefitinib—CYP1A1—digestive system—ulcerative colitis	0.000342	0.0103	CbGeAlD
Gefitinib—CYP3A5—digestive system—ulcerative colitis	0.000334	0.01	CbGeAlD
Gefitinib—CYP2C9—digestive system—ulcerative colitis	0.000329	0.00987	CbGeAlD
Gefitinib—CYP2C19—liver—ulcerative colitis	0.000316	0.00948	CbGeAlD
Gefitinib—Erlotinib—ALB—ulcerative colitis	0.000299	0.0729	CrCbGaD
Gefitinib—Erlotinib—ABCB1—ulcerative colitis	0.000285	0.0696	CrCbGaD
Gefitinib—CSNK1E—Betamethasone—Budesonide—ulcerative colitis	0.000283	0.0747	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Budesonide—ulcerative colitis	0.000283	0.0747	CbGdCrCtD
Gefitinib—ABCG2—liver—ulcerative colitis	0.000268	0.00805	CbGeAlD
Gefitinib—CYP1A1—liver—ulcerative colitis	0.000254	0.00764	CbGeAlD
Gefitinib—CYP3A4—digestive system—ulcerative colitis	0.000251	0.00752	CbGeAlD
Gefitinib—CYP3A5—liver—ulcerative colitis	0.000249	0.00747	CbGeAlD
Gefitinib—CYP2D6—digestive system—ulcerative colitis	0.000247	0.0074	CbGeAlD
Gefitinib—CYP2C9—liver—ulcerative colitis	0.000245	0.00735	CbGeAlD
Gefitinib—ABCB1—epithelium—ulcerative colitis	0.000233	0.007	CbGeAlD
Gefitinib—CSNK1E—Danazol—Hydrocortisone—ulcerative colitis	0.000227	0.0599	CbGdCrCtD
Gefitinib—Vandetanib—ALB—ulcerative colitis	0.000197	0.048	CrCbGaD
Gefitinib—CSNK1E—Danazol—Prednisone—ulcerative colitis	0.000195	0.0516	CbGdCrCtD
Gefitinib—Decreased appetite—Budesonide—ulcerative colitis	0.000192	0.00157	CcSEcCtD
Gefitinib—Skin disorder—Azathioprine—ulcerative colitis	0.000191	0.00157	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.00019	0.00156	CcSEcCtD
Gefitinib—Nausea—Nicotine—ulcerative colitis	0.00019	0.00156	CcSEcCtD
Gefitinib—Fatigue—Budesonide—ulcerative colitis	0.00019	0.00156	CcSEcCtD
Gefitinib—Pain—Budesonide—ulcerative colitis	0.000189	0.00155	CcSEcCtD
Gefitinib—Constipation—Budesonide—ulcerative colitis	0.000189	0.00155	CcSEcCtD
Gefitinib—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000188	0.00154	CcSEcCtD
Gefitinib—Infestation—Methylprednisolone—ulcerative colitis	0.000188	0.00154	CcSEcCtD
Gefitinib—CYP3A4—liver—ulcerative colitis	0.000187	0.00561	CbGeAlD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000186	0.00153	CcSEcCtD
Gefitinib—Haemoglobin—Prednisolone—ulcerative colitis	0.000185	0.00152	CcSEcCtD
Gefitinib—Hypotension—Azathioprine—ulcerative colitis	0.000184	0.00151	CcSEcCtD
Gefitinib—CYP2D6—liver—ulcerative colitis	0.000184	0.00552	CbGeAlD
Gefitinib—Haemorrhage—Prednisolone—ulcerative colitis	0.000184	0.00151	CcSEcCtD
Gefitinib—Conjunctivitis—Triamcinolone—ulcerative colitis	0.000183	0.0015	CcSEcCtD
Gefitinib—Dry mouth—Mesalazine—ulcerative colitis	0.000183	0.0015	CcSEcCtD
Gefitinib—Haemoglobin—Hydrocortisone—ulcerative colitis	0.00018	0.00148	CcSEcCtD
Gefitinib—Gastrointestinal pain—Budesonide—ulcerative colitis	0.00018	0.00148	CcSEcCtD
Gefitinib—ABCB1—lymphoid tissue—ulcerative colitis	0.00018	0.00539	CbGeAlD
Gefitinib—Haemorrhage—Hydrocortisone—ulcerative colitis	0.000179	0.00147	CcSEcCtD
Gefitinib—Infection—Mesalazine—ulcerative colitis	0.000178	0.00146	CcSEcCtD
Gefitinib—Epistaxis—Triamcinolone—ulcerative colitis	0.000178	0.00146	CcSEcCtD
Gefitinib—ABCB1—digestive system—ulcerative colitis	0.000177	0.00533	CbGeAlD
Gefitinib—Dry skin—Prednisone—ulcerative colitis	0.000177	0.00145	CcSEcCtD
Gefitinib—Shock—Mesalazine—ulcerative colitis	0.000176	0.00145	CcSEcCtD
Gefitinib—Nervous system disorder—Mesalazine—ulcerative colitis	0.000176	0.00144	CcSEcCtD
Gefitinib—Bosutinib—ABCB1—ulcerative colitis	0.000176	0.0429	CrCbGaD
Gefitinib—Hypokalaemia—Prednisone—ulcerative colitis	0.000176	0.00144	CcSEcCtD
Gefitinib—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000176	0.00144	CcSEcCtD
Gefitinib—Urticaria—Budesonide—ulcerative colitis	0.000175	0.00144	CcSEcCtD
Gefitinib—Abdominal pain—Budesonide—ulcerative colitis	0.000174	0.00143	CcSEcCtD
Gefitinib—Body temperature increased—Budesonide—ulcerative colitis	0.000174	0.00143	CcSEcCtD
Gefitinib—Skin disorder—Mesalazine—ulcerative colitis	0.000174	0.00143	CcSEcCtD
Gefitinib—Weight decreased—Dexamethasone—ulcerative colitis	0.000173	0.00142	CcSEcCtD
Gefitinib—Weight decreased—Betamethasone—ulcerative colitis	0.000173	0.00142	CcSEcCtD
Gefitinib—Anorexia—Mesalazine—ulcerative colitis	0.000171	0.0014	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.00017	0.0014	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00017	0.0014	CcSEcCtD
Gefitinib—Haemoglobin—Triamcinolone—ulcerative colitis	0.00017	0.00139	CcSEcCtD
Gefitinib—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000169	0.00139	CcSEcCtD
Gefitinib—Haemorrhage—Triamcinolone—ulcerative colitis	0.000169	0.00139	CcSEcCtD
Gefitinib—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000169	0.00138	CcSEcCtD
Gefitinib—Eye disorder—Hydrocortisone—ulcerative colitis	0.000168	0.00138	CcSEcCtD
Gefitinib—Hypotension—Mesalazine—ulcerative colitis	0.000168	0.00138	CcSEcCtD
Gefitinib—Conjunctivitis—Betamethasone—ulcerative colitis	0.000166	0.00136	CcSEcCtD
Gefitinib—Conjunctivitis—Dexamethasone—ulcerative colitis	0.000166	0.00136	CcSEcCtD
Gefitinib—Arrhythmia—Prednisolone—ulcerative colitis	0.000164	0.00135	CcSEcCtD
Gefitinib—Pancreatitis—Prednisone—ulcerative colitis	0.000164	0.00134	CcSEcCtD
Gefitinib—Hypersensitivity—Budesonide—ulcerative colitis	0.000162	0.00133	CcSEcCtD
Gefitinib—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000161	0.00132	CcSEcCtD
Gefitinib—Arrhythmia—Hydrocortisone—ulcerative colitis	0.00016	0.00132	CcSEcCtD
Gefitinib—Dyspnoea—Mesalazine—ulcerative colitis	0.00016	0.00131	CcSEcCtD
Gefitinib—Asthenia—Budesonide—ulcerative colitis	0.000158	0.0013	CcSEcCtD
Gefitinib—Eye disorder—Methylprednisolone—ulcerative colitis	0.000158	0.00129	CcSEcCtD
Gefitinib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000156	0.00129	CcSEcCtD
Gefitinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000156	0.00128	CcSEcCtD
Gefitinib—Pruritus—Budesonide—ulcerative colitis	0.000156	0.00128	CcSEcCtD
Gefitinib—Decreased appetite—Mesalazine—ulcerative colitis	0.000156	0.00128	CcSEcCtD
Gefitinib—Abdominal pain—Azathioprine—ulcerative colitis	0.000156	0.00128	CcSEcCtD
Gefitinib—Body temperature increased—Azathioprine—ulcerative colitis	0.000156	0.00128	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000155	0.00127	CcSEcCtD
Gefitinib—Fatigue—Mesalazine—ulcerative colitis	0.000155	0.00127	CcSEcCtD
Gefitinib—Haemoglobin—Dexamethasone—ulcerative colitis	0.000154	0.00127	CcSEcCtD
Gefitinib—Haemoglobin—Betamethasone—ulcerative colitis	0.000154	0.00127	CcSEcCtD
Gefitinib—Constipation—Mesalazine—ulcerative colitis	0.000153	0.00126	CcSEcCtD
Gefitinib—Pain—Mesalazine—ulcerative colitis	0.000153	0.00126	CcSEcCtD
Gefitinib—Haemorrhage—Betamethasone—ulcerative colitis	0.000153	0.00126	CcSEcCtD
Gefitinib—Haemorrhage—Dexamethasone—ulcerative colitis	0.000153	0.00126	CcSEcCtD
Gefitinib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000153	0.00126	CcSEcCtD
Gefitinib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000152	0.00125	CcSEcCtD
Gefitinib—Arrhythmia—Triamcinolone—ulcerative colitis	0.000151	0.00124	CcSEcCtD
Gefitinib—Weight decreased—Prednisone—ulcerative colitis	0.000151	0.00124	CcSEcCtD
Gefitinib—Diarrhoea—Budesonide—ulcerative colitis	0.000151	0.00124	CcSEcCtD
Gefitinib—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000151	0.00124	CcSEcCtD
Gefitinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000147	0.00121	CcSEcCtD
Gefitinib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000147	0.0012	CcSEcCtD
Gefitinib—Angioedema—Prednisolone—ulcerative colitis	0.000146	0.0012	CcSEcCtD
Gefitinib—Hypersensitivity—Azathioprine—ulcerative colitis	0.000145	0.00119	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000145	0.0382	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Hydrocortisone—ulcerative colitis	0.000145	0.0382	CbGdCrCtD
Gefitinib—Malaise—Prednisolone—ulcerative colitis	0.000144	0.00118	CcSEcCtD
Gefitinib—Eye disorder—Dexamethasone—ulcerative colitis	0.000143	0.00118	CcSEcCtD
Gefitinib—Eye disorder—Betamethasone—ulcerative colitis	0.000143	0.00118	CcSEcCtD
Gefitinib—Angioedema—Hydrocortisone—ulcerative colitis	0.000143	0.00117	CcSEcCtD
Gefitinib—Urticaria—Mesalazine—ulcerative colitis	0.000142	0.00117	CcSEcCtD
Gefitinib—Body temperature increased—Mesalazine—ulcerative colitis	0.000142	0.00116	CcSEcCtD
Gefitinib—Abdominal pain—Mesalazine—ulcerative colitis	0.000142	0.00116	CcSEcCtD
Gefitinib—Malaise—Hydrocortisone—ulcerative colitis	0.000141	0.00116	CcSEcCtD
Gefitinib—Vomiting—Budesonide—ulcerative colitis	0.00014	0.00115	CcSEcCtD
Gefitinib—CHEK2—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.00014	0.0369	CbGdCrCtD
Gefitinib—Angiopathy—Betamethasone—ulcerative colitis	0.000139	0.00114	CcSEcCtD
Gefitinib—Angiopathy—Dexamethasone—ulcerative colitis	0.000139	0.00114	CcSEcCtD
Gefitinib—Rash—Budesonide—ulcerative colitis	0.000139	0.00114	CcSEcCtD
Gefitinib—Dermatitis—Budesonide—ulcerative colitis	0.000139	0.00114	CcSEcCtD
Gefitinib—Arrhythmia—Dexamethasone—ulcerative colitis	0.000137	0.00112	CcSEcCtD
Gefitinib—Arrhythmia—Betamethasone—ulcerative colitis	0.000137	0.00112	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Methylprednisolone—ulcerative colitis	0.000137	0.0361	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000137	0.0361	CbGdCrCtD
Gefitinib—Alopecia—Dexamethasone—ulcerative colitis	0.000135	0.00111	CcSEcCtD
Gefitinib—Alopecia—Betamethasone—ulcerative colitis	0.000135	0.00111	CcSEcCtD
Gefitinib—Diarrhoea—Azathioprine—ulcerative colitis	0.000135	0.00111	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Dexamethasone—ulcerative colitis	0.000134	0.0355	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Betamethasone—ulcerative colitis	0.000134	0.0355	CbGdCrCtD
Gefitinib—Angioedema—Triamcinolone—ulcerative colitis	0.000134	0.0011	CcSEcCtD
Gefitinib—Haemoglobin—Prednisone—ulcerative colitis	0.000134	0.0011	CcSEcCtD
Gefitinib—Angioedema—Methylprednisolone—ulcerative colitis	0.000134	0.0011	CcSEcCtD
Gefitinib—Haemorrhage—Prednisone—ulcerative colitis	0.000134	0.0011	CcSEcCtD
Gefitinib—Malaise—Triamcinolone—ulcerative colitis	0.000133	0.00109	CcSEcCtD
Gefitinib—Malaise—Methylprednisolone—ulcerative colitis	0.000132	0.00109	CcSEcCtD
Gefitinib—ABCB1—liver—ulcerative colitis	0.000132	0.00397	CbGeAlD
Gefitinib—Hypersensitivity—Mesalazine—ulcerative colitis	0.000132	0.00108	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000132	0.00108	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Triamcinolone—ulcerative colitis	0.000131	0.0347	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Triamcinolone—ulcerative colitis	0.000131	0.0347	CbGdCrCtD
Gefitinib—Nausea—Budesonide—ulcerative colitis	0.000131	0.00108	CcSEcCtD
Gefitinib—Asthenia—Mesalazine—ulcerative colitis	0.000129	0.00106	CcSEcCtD
Gefitinib—Shock—Prednisolone—ulcerative colitis	0.000128	0.00105	CcSEcCtD
Gefitinib—Cough—Triamcinolone—ulcerative colitis	0.000128	0.00105	CcSEcCtD
Gefitinib—Pruritus—Mesalazine—ulcerative colitis	0.000127	0.00104	CcSEcCtD
Gefitinib—Infection—Hydrocortisone—ulcerative colitis	0.000127	0.00104	CcSEcCtD
Gefitinib—Shock—Hydrocortisone—ulcerative colitis	0.000125	0.00103	CcSEcCtD
Gefitinib—Vomiting—Azathioprine—ulcerative colitis	0.000125	0.00103	CcSEcCtD
Gefitinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000125	0.00103	CcSEcCtD
Gefitinib—Eye disorder—Prednisone—ulcerative colitis	0.000125	0.00102	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisone—ulcerative colitis	0.000125	0.0329	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Prednisone—ulcerative colitis	0.000125	0.0329	CbGdCrCtD
Gefitinib—Rash—Azathioprine—ulcerative colitis	0.000124	0.00102	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000124	0.00102	CcSEcCtD
Gefitinib—Dermatitis—Azathioprine—ulcerative colitis	0.000124	0.00102	CcSEcCtD
Gefitinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000124	0.00102	CcSEcCtD
Gefitinib—Diarrhoea—Mesalazine—ulcerative colitis	0.000123	0.00101	CcSEcCtD
Gefitinib—Dry mouth—Triamcinolone—ulcerative colitis	0.000122	0.00101	CcSEcCtD
Gefitinib—Angioedema—Dexamethasone—ulcerative colitis	0.000122	0.001	CcSEcCtD
Gefitinib—Angioedema—Betamethasone—ulcerative colitis	0.000122	0.001	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Prednisolone—ulcerative colitis	0.000122	0.0321	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisolone—ulcerative colitis	0.000122	0.0321	CbGdCrCtD
Gefitinib—Anorexia—Hydrocortisone—ulcerative colitis	0.000122	0.000998	CcSEcCtD
Gefitinib—Angiopathy—Prednisone—ulcerative colitis	0.000121	0.000995	CcSEcCtD
Gefitinib—Malaise—Betamethasone—ulcerative colitis	0.00012	0.000989	CcSEcCtD
Gefitinib—Malaise—Dexamethasone—ulcerative colitis	0.00012	0.000989	CcSEcCtD
Gefitinib—Arrhythmia—Prednisone—ulcerative colitis	0.000119	0.00098	CcSEcCtD
Gefitinib—Infection—Triamcinolone—ulcerative colitis	0.000119	0.00098	CcSEcCtD
Gefitinib—Hypotension—Hydrocortisone—ulcerative colitis	0.000119	0.000978	CcSEcCtD
Gefitinib—Infection—Methylprednisolone—ulcerative colitis	0.000119	0.000977	CcSEcCtD
Gefitinib—Shock—Triamcinolone—ulcerative colitis	0.000118	0.00097	CcSEcCtD
Gefitinib—Alopecia—Prednisone—ulcerative colitis	0.000118	0.000969	CcSEcCtD
Gefitinib—Shock—Methylprednisolone—ulcerative colitis	0.000118	0.000968	CcSEcCtD
Gefitinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000117	0.000965	CcSEcCtD
Gefitinib—Nausea—Azathioprine—ulcerative colitis	0.000117	0.00096	CcSEcCtD
Gefitinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000116	0.000956	CcSEcCtD
Gefitinib—Malnutrition—Prednisone—ulcerative colitis	0.000116	0.000955	CcSEcCtD
Gefitinib—CHEK2—Danazol—Hydrocortisone—ulcerative colitis	0.000116	0.0307	CbGdCrCtD
Gefitinib—Vomiting—Mesalazine—ulcerative colitis	0.000114	0.000936	CcSEcCtD
Gefitinib—Rash—Mesalazine—ulcerative colitis	0.000113	0.000928	CcSEcCtD
Gefitinib—Dermatitis—Mesalazine—ulcerative colitis	0.000113	0.000928	CcSEcCtD
Gefitinib—Hypotension—Methylprednisolone—ulcerative colitis	0.000112	0.000919	CcSEcCtD
Gefitinib—Pain—Prednisolone—ulcerative colitis	0.000112	0.000917	CcSEcCtD
Gefitinib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000111	0.00091	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00011	0.000904	CcSEcCtD
Gefitinib—Fatigue—Hydrocortisone—ulcerative colitis	0.00011	0.000903	CcSEcCtD
Gefitinib—Pain—Hydrocortisone—ulcerative colitis	0.000109	0.000895	CcSEcCtD
Gefitinib—Infection—Betamethasone—ulcerative colitis	0.000108	0.000889	CcSEcCtD
Gefitinib—Infection—Dexamethasone—ulcerative colitis	0.000108	0.000889	CcSEcCtD
Gefitinib—Anaemia—Prednisone—ulcerative colitis	0.000107	0.000882	CcSEcCtD
Gefitinib—Shock—Dexamethasone—ulcerative colitis	0.000107	0.00088	CcSEcCtD
Gefitinib—Shock—Betamethasone—ulcerative colitis	0.000107	0.00088	CcSEcCtD
Gefitinib—Dyspnoea—Triamcinolone—ulcerative colitis	0.000107	0.000879	CcSEcCtD
Gefitinib—Nervous system disorder—Betamethasone—ulcerative colitis	0.000107	0.000877	CcSEcCtD
Gefitinib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000107	0.000877	CcSEcCtD
Gefitinib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000107	0.000876	CcSEcCtD
Gefitinib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000107	0.000876	CcSEcCtD
Gefitinib—Nausea—Mesalazine—ulcerative colitis	0.000106	0.000875	CcSEcCtD
Gefitinib—Angioedema—Prednisone—ulcerative colitis	0.000106	0.000872	CcSEcCtD
Gefitinib—Malaise—Prednisone—ulcerative colitis	0.000105	0.000861	CcSEcCtD
Gefitinib—CHEK2—Norethindrone—Hydrocortisone—ulcerative colitis	0.000105	0.0276	CbGdCrCtD
Gefitinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000104	0.000856	CcSEcCtD
Gefitinib—Anorexia—Dexamethasone—ulcerative colitis	0.000104	0.000853	CcSEcCtD
Gefitinib—Anorexia—Betamethasone—ulcerative colitis	0.000104	0.000853	CcSEcCtD
Gefitinib—Urticaria—Prednisolone—ulcerative colitis	0.000104	0.000852	CcSEcCtD
Gefitinib—Fatigue—Triamcinolone—ulcerative colitis	0.000103	0.00085	CcSEcCtD
Gefitinib—Fatigue—Methylprednisolone—ulcerative colitis	0.000103	0.000848	CcSEcCtD
Gefitinib—Pain—Triamcinolone—ulcerative colitis	0.000103	0.000843	CcSEcCtD
Gefitinib—Hypotension—Dexamethasone—ulcerative colitis	0.000102	0.000836	CcSEcCtD
Gefitinib—Hypotension—Betamethasone—ulcerative colitis	0.000102	0.000836	CcSEcCtD
Gefitinib—Urticaria—Hydrocortisone—ulcerative colitis	0.000101	0.000832	CcSEcCtD
Gefitinib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000101	0.000828	CcSEcCtD
Gefitinib—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000101	0.000828	CcSEcCtD
Gefitinib—CHEK2—Danazol—Prednisone—ulcerative colitis	9.99e-05	0.0264	CbGdCrCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	9.83e-05	0.000807	CcSEcCtD
Gefitinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	9.79e-05	0.000804	CcSEcCtD
Gefitinib—Hypersensitivity—Prednisolone—ulcerative colitis	9.62e-05	0.00079	CcSEcCtD
Gefitinib—Urticaria—Triamcinolone—ulcerative colitis	9.54e-05	0.000783	CcSEcCtD
Gefitinib—Urticaria—Methylprednisolone—ulcerative colitis	9.52e-05	0.000782	CcSEcCtD
Gefitinib—Body temperature increased—Triamcinolone—ulcerative colitis	9.49e-05	0.000779	CcSEcCtD
Gefitinib—Abdominal pain—Methylprednisolone—ulcerative colitis	9.47e-05	0.000778	CcSEcCtD
Gefitinib—Decreased appetite—Dexamethasone—ulcerative colitis	9.47e-05	0.000778	CcSEcCtD
Gefitinib—Decreased appetite—Betamethasone—ulcerative colitis	9.47e-05	0.000778	CcSEcCtD
Gefitinib—Infection—Prednisone—ulcerative colitis	9.42e-05	0.000774	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.4e-05	0.000772	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.4e-05	0.000772	CcSEcCtD
Gefitinib—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.39e-05	0.000771	CcSEcCtD
Gefitinib—Fatigue—Dexamethasone—ulcerative colitis	9.39e-05	0.000771	CcSEcCtD
Gefitinib—Fatigue—Betamethasone—ulcerative colitis	9.39e-05	0.000771	CcSEcCtD
Gefitinib—Shock—Prednisone—ulcerative colitis	9.33e-05	0.000767	CcSEcCtD
Gefitinib—Pain—Betamethasone—ulcerative colitis	9.31e-05	0.000765	CcSEcCtD
Gefitinib—Pain—Dexamethasone—ulcerative colitis	9.31e-05	0.000765	CcSEcCtD
Gefitinib—Nervous system disorder—Prednisone—ulcerative colitis	9.3e-05	0.000764	CcSEcCtD
Gefitinib—Skin disorder—Prednisone—ulcerative colitis	9.21e-05	0.000757	CcSEcCtD
Gefitinib—Asthenia—Hydrocortisone—ulcerative colitis	9.15e-05	0.000751	CcSEcCtD
Gefitinib—Anorexia—Prednisone—ulcerative colitis	9.04e-05	0.000743	CcSEcCtD
Gefitinib—Pruritus—Hydrocortisone—ulcerative colitis	9.02e-05	0.000741	CcSEcCtD
Gefitinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	8.91e-05	0.000732	CcSEcCtD
Gefitinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	8.91e-05	0.000732	CcSEcCtD
Gefitinib—Hypersensitivity—Triamcinolone—ulcerative colitis	8.84e-05	0.000726	CcSEcCtD
Gefitinib—Hypersensitivity—Methylprednisolone—ulcerative colitis	8.82e-05	0.000725	CcSEcCtD
Gefitinib—Diarrhoea—Hydrocortisone—ulcerative colitis	8.72e-05	0.000716	CcSEcCtD
Gefitinib—Urticaria—Betamethasone—ulcerative colitis	8.65e-05	0.000711	CcSEcCtD
Gefitinib—Urticaria—Dexamethasone—ulcerative colitis	8.65e-05	0.000711	CcSEcCtD
Gefitinib—Asthenia—Triamcinolone—ulcerative colitis	8.61e-05	0.000707	CcSEcCtD
Gefitinib—Abdominal pain—Betamethasone—ulcerative colitis	8.61e-05	0.000707	CcSEcCtD
Gefitinib—Body temperature increased—Dexamethasone—ulcerative colitis	8.61e-05	0.000707	CcSEcCtD
Gefitinib—Abdominal pain—Dexamethasone—ulcerative colitis	8.61e-05	0.000707	CcSEcCtD
Gefitinib—Body temperature increased—Betamethasone—ulcerative colitis	8.61e-05	0.000707	CcSEcCtD
Gefitinib—Asthenia—Methylprednisolone—ulcerative colitis	8.59e-05	0.000706	CcSEcCtD
Gefitinib—Pruritus—Triamcinolone—ulcerative colitis	8.49e-05	0.000698	CcSEcCtD
Gefitinib—Pruritus—Methylprednisolone—ulcerative colitis	8.47e-05	0.000696	CcSEcCtD
Gefitinib—CHEK2—Levonorgestrel—Hydrocortisone—ulcerative colitis	8.32e-05	0.022	CbGdCrCtD
Gefitinib—Decreased appetite—Prednisone—ulcerative colitis	8.25e-05	0.000677	CcSEcCtD
Gefitinib—Rash—Prednisolone—ulcerative colitis	8.23e-05	0.000676	CcSEcCtD
Gefitinib—Dermatitis—Prednisolone—ulcerative colitis	8.22e-05	0.000675	CcSEcCtD
Gefitinib—Diarrhoea—Methylprednisolone—ulcerative colitis	8.2e-05	0.000673	CcSEcCtD
Gefitinib—Fatigue—Prednisone—ulcerative colitis	8.18e-05	0.000672	CcSEcCtD
Gefitinib—Constipation—Prednisone—ulcerative colitis	8.11e-05	0.000666	CcSEcCtD
Gefitinib—Vomiting—Hydrocortisone—ulcerative colitis	8.11e-05	0.000666	CcSEcCtD
Gefitinib—Rash—Hydrocortisone—ulcerative colitis	8.04e-05	0.00066	CcSEcCtD
Gefitinib—Dermatitis—Hydrocortisone—ulcerative colitis	8.03e-05	0.00066	CcSEcCtD
Gefitinib—Asthenia—Betamethasone—ulcerative colitis	7.81e-05	0.000642	CcSEcCtD
Gefitinib—Asthenia—Dexamethasone—ulcerative colitis	7.81e-05	0.000642	CcSEcCtD
Gefitinib—Gastrointestinal pain—Prednisone—ulcerative colitis	7.76e-05	0.000637	CcSEcCtD
Gefitinib—Nausea—Prednisolone—ulcerative colitis	7.75e-05	0.000637	CcSEcCtD
Gefitinib—Pruritus—Betamethasone—ulcerative colitis	7.71e-05	0.000633	CcSEcCtD
Gefitinib—Pruritus—Dexamethasone—ulcerative colitis	7.71e-05	0.000633	CcSEcCtD
Gefitinib—Vomiting—Triamcinolone—ulcerative colitis	7.63e-05	0.000627	CcSEcCtD
Gefitinib—Vomiting—Methylprednisolone—ulcerative colitis	7.62e-05	0.000626	CcSEcCtD
Gefitinib—Nausea—Hydrocortisone—ulcerative colitis	7.57e-05	0.000622	CcSEcCtD
Gefitinib—Rash—Triamcinolone—ulcerative colitis	7.57e-05	0.000622	CcSEcCtD
Gefitinib—Dermatitis—Triamcinolone—ulcerative colitis	7.56e-05	0.000621	CcSEcCtD
Gefitinib—Rash—Methylprednisolone—ulcerative colitis	7.55e-05	0.00062	CcSEcCtD
Gefitinib—Dermatitis—Methylprednisolone—ulcerative colitis	7.54e-05	0.00062	CcSEcCtD
Gefitinib—Urticaria—Prednisone—ulcerative colitis	7.54e-05	0.000619	CcSEcCtD
Gefitinib—Body temperature increased—Prednisone—ulcerative colitis	7.5e-05	0.000616	CcSEcCtD
Gefitinib—Abdominal pain—Prednisone—ulcerative colitis	7.5e-05	0.000616	CcSEcCtD
Gefitinib—Diarrhoea—Betamethasone—ulcerative colitis	7.45e-05	0.000612	CcSEcCtD
Gefitinib—Diarrhoea—Dexamethasone—ulcerative colitis	7.45e-05	0.000612	CcSEcCtD
Gefitinib—Nausea—Triamcinolone—ulcerative colitis	7.13e-05	0.000586	CcSEcCtD
Gefitinib—Nausea—Methylprednisolone—ulcerative colitis	7.11e-05	0.000584	CcSEcCtD
Gefitinib—Hypersensitivity—Prednisone—ulcerative colitis	6.99e-05	0.000574	CcSEcCtD
Gefitinib—Vomiting—Dexamethasone—ulcerative colitis	6.93e-05	0.000569	CcSEcCtD
Gefitinib—Vomiting—Betamethasone—ulcerative colitis	6.93e-05	0.000569	CcSEcCtD
Gefitinib—Rash—Dexamethasone—ulcerative colitis	6.87e-05	0.000564	CcSEcCtD
Gefitinib—Rash—Betamethasone—ulcerative colitis	6.87e-05	0.000564	CcSEcCtD
Gefitinib—Dermatitis—Dexamethasone—ulcerative colitis	6.86e-05	0.000564	CcSEcCtD
Gefitinib—Dermatitis—Betamethasone—ulcerative colitis	6.86e-05	0.000564	CcSEcCtD
Gefitinib—Asthenia—Prednisone—ulcerative colitis	6.81e-05	0.000559	CcSEcCtD
Gefitinib—Pruritus—Prednisone—ulcerative colitis	6.71e-05	0.000551	CcSEcCtD
Gefitinib—Diarrhoea—Prednisone—ulcerative colitis	6.49e-05	0.000533	CcSEcCtD
Gefitinib—Nausea—Dexamethasone—ulcerative colitis	6.47e-05	0.000531	CcSEcCtD
Gefitinib—Nausea—Betamethasone—ulcerative colitis	6.47e-05	0.000531	CcSEcCtD
Gefitinib—Vomiting—Prednisone—ulcerative colitis	6.03e-05	0.000495	CcSEcCtD
Gefitinib—Rash—Prednisone—ulcerative colitis	5.98e-05	0.000491	CcSEcCtD
Gefitinib—Dermatitis—Prednisone—ulcerative colitis	5.98e-05	0.000491	CcSEcCtD
Gefitinib—Nausea—Prednisone—ulcerative colitis	5.63e-05	0.000463	CcSEcCtD
Gefitinib—MKNK1—Signaling Pathways—JAK2—ulcerative colitis	1.33e-05	0.000109	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCR2—ulcerative colitis	1.32e-05	0.000108	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—JAK2—ulcerative colitis	1.32e-05	0.000108	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.32e-05	0.000108	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ADCY5—ulcerative colitis	1.31e-05	0.000107	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—ICAM1—ulcerative colitis	1.31e-05	0.000107	CbGpPWpGaD
Gefitinib—MKNK1—Disease—TGFB1—ulcerative colitis	1.29e-05	0.000106	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—RELA—ulcerative colitis	1.29e-05	0.000106	CbGpPWpGaD
Gefitinib—EGFR—Immune System—VCAM1—ulcerative colitis	1.29e-05	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DQA1—ulcerative colitis	1.28e-05	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—RELA—ulcerative colitis	1.28e-05	0.000105	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CDH1—ulcerative colitis	1.28e-05	0.000105	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DLD—ulcerative colitis	1.27e-05	0.000104	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ADCY5—ulcerative colitis	1.26e-05	0.000104	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	1.26e-05	0.000103	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DLD—ulcerative colitis	1.26e-05	0.000103	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NFKB1—ulcerative colitis	1.25e-05	0.000102	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCR6—ulcerative colitis	1.24e-05	0.000102	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ADRB2—ulcerative colitis	1.24e-05	0.000102	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—JAK2—ulcerative colitis	1.22e-05	9.99e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CXCL8—ulcerative colitis	1.21e-05	9.95e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS1—ulcerative colitis	1.2e-05	9.86e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IFNG—ulcerative colitis	1.2e-05	9.81e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—ADCY5—ulcerative colitis	1.19e-05	9.76e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—RELA—ulcerative colitis	1.18e-05	9.68e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MAML2—ulcerative colitis	1.18e-05	9.66e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—JAK2—ulcerative colitis	1.16e-05	9.55e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.16e-05	9.53e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL2—ulcerative colitis	1.16e-05	9.51e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CDH1—ulcerative colitis	1.16e-05	9.49e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD4—ulcerative colitis	1.16e-05	9.47e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—RELA—ulcerative colitis	1.13e-05	9.25e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—JAK2—ulcerative colitis	1.12e-05	9.22e-05	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.12e-05	9.22e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—STAT3—ulcerative colitis	1.12e-05	9.2e-05	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	1.11e-05	9.1e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD4—ulcerative colitis	1.1e-05	9.05e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MMP9—ulcerative colitis	1.1e-05	9e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PTGER4—ulcerative colitis	1.09e-05	8.97e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP9—ulcerative colitis	1.09e-05	8.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ADCY5—ulcerative colitis	1.09e-05	8.92e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NFKB1—ulcerative colitis	1.09e-05	8.9e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—STAT3—ulcerative colitis	1.08e-05	8.89e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—RELA—ulcerative colitis	1.08e-05	8.88e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CALM3—ulcerative colitis	1.08e-05	8.88e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NFKB1—ulcerative colitis	1.08e-05	8.83e-05	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—IL6—ulcerative colitis	1.07e-05	8.79e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1B—ulcerative colitis	1.07e-05	8.75e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD4—ulcerative colitis	1.07e-05	8.74e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL2—ulcerative colitis	1.06e-05	8.71e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD4—ulcerative colitis	1.06e-05	8.69e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTGS2—ulcerative colitis	1.06e-05	8.68e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—MMP1—ulcerative colitis	1.06e-05	8.67e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ADCY5—ulcerative colitis	1.05e-05	8.63e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—IL6—ulcerative colitis	1.05e-05	8.58e-05	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.03e-05	8.48e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—JAK2—ulcerative colitis	1.03e-05	8.48e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—JAK2—ulcerative colitis	1.01e-05	8.32e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—ADCY5—ulcerative colitis	1e-05	8.24e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TGFB1—ulcerative colitis	1e-05	8.24e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RELA—ulcerative colitis	1e-05	8.21e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GHRL—ulcerative colitis	1e-05	8.21e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IFNG—ulcerative colitis	9.96e-06	8.17e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NFKB1—ulcerative colitis	9.95e-06	8.16e-05	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	9.84e-06	8.07e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—RELA—ulcerative colitis	9.82e-06	8.06e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—STAT3—ulcerative colitis	9.76e-06	8e-05	CbGpPWpGaD
Gefitinib—MKNK1—Disease—IL6—ulcerative colitis	9.73e-06	7.98e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CALM3—ulcerative colitis	9.7e-06	7.95e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	9.69e-06	7.94e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—STAT3—ulcerative colitis	9.68e-06	7.94e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD4—ulcerative colitis	9.62e-06	7.89e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.6e-06	7.87e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RIPK2—ulcerative colitis	9.55e-06	7.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CRP—ulcerative colitis	9.52e-06	7.81e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NFKB1—ulcerative colitis	9.51e-06	7.8e-05	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—IL6—ulcerative colitis	9.47e-06	7.77e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CXCL8—ulcerative colitis	9.44e-06	7.74e-05	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NFKB1—ulcerative colitis	9.13e-06	7.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TLR4—ulcerative colitis	9.13e-06	7.48e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—HLA-DRB1—ulcerative colitis	9.12e-06	7.48e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	9.07e-06	7.43e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TGFB1—ulcerative colitis	9.05e-06	7.42e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	9.04e-06	7.42e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL2—ulcerative colitis	9.02e-06	7.39e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TGFB1—ulcerative colitis	8.97e-06	7.36e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—STAT3—ulcerative colitis	8.94e-06	7.33e-05	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—IL6—ulcerative colitis	8.93e-06	7.32e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.9e-06	7.3e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1B—ulcerative colitis	8.88e-06	7.28e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL2—ulcerative colitis	8.85e-06	7.26e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ICAM1—ulcerative colitis	8.75e-06	7.18e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS1—ulcerative colitis	8.62e-06	7.06e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP9—ulcerative colitis	8.53e-06	7e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NFKB1—ulcerative colitis	8.44e-06	6.92e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ABCB1—ulcerative colitis	8.42e-06	6.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TNF—ulcerative colitis	8.38e-06	6.87e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADRB2—ulcerative colitis	8.29e-06	6.8e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NFKB1—ulcerative colitis	8.29e-06	6.79e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DLD—ulcerative colitis	8.28e-06	6.79e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—STAT3—ulcerative colitis	8.26e-06	6.77e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—JAK2—ulcerative colitis	8.17e-06	6.7e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS1—ulcerative colitis	8.14e-06	6.67e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.12e-06	6.66e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	8.01e-06	6.56e-05	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	7.97e-06	6.54e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RELA—ulcerative colitis	7.92e-06	6.49e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—JAK2—ulcerative colitis	7.88e-06	6.46e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ADCY5—ulcerative colitis	7.85e-06	6.44e-05	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL6—ulcerative colitis	7.84e-06	6.42e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CALM3—ulcerative colitis	7.76e-06	6.36e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CDH1—ulcerative colitis	7.74e-06	6.34e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TGFB1—ulcerative colitis	7.65e-06	6.28e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RELA—ulcerative colitis	7.63e-06	6.26e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—STAT3—ulcerative colitis	7.59e-06	6.22e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—IL6—ulcerative colitis	7.57e-06	6.21e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL8—ulcerative colitis	7.46e-06	6.12e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—JAK2—ulcerative colitis	7.45e-06	6.11e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—ulcerative colitis	7.45e-06	6.11e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—STAT3—ulcerative colitis	7.45e-06	6.11e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—JAK2—ulcerative colitis	7.42e-06	6.09e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS1—ulcerative colitis	7.42e-06	6.08e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CALM3—ulcerative colitis	7.33e-06	6.01e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.29e-06	5.97e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL8—ulcerative colitis	7.19e-06	5.9e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL2—ulcerative colitis	7.13e-06	5.85e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADCY5—ulcerative colitis	7.03e-06	5.77e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TGFB1—ulcerative colitis	7.03e-06	5.77e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	7e-06	5.74e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL2—ulcerative colitis	6.87e-06	5.63e-05	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—IL6—ulcerative colitis	6.82e-06	5.59e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—JAK2—ulcerative colitis	6.78e-06	5.56e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL8—ulcerative colitis	6.78e-06	5.56e-05	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—IL6—ulcerative colitis	6.76e-06	5.54e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP9—ulcerative colitis	6.75e-06	5.53e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CALM3—ulcerative colitis	6.68e-06	5.48e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NFKB1—ulcerative colitis	6.68e-06	5.47e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	6.66e-06	5.46e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IFNG—ulcerative colitis	6.66e-06	5.46e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.64e-06	5.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—RELA—ulcerative colitis	6.57e-06	5.39e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—JAK2—ulcerative colitis	6.56e-06	5.38e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.55e-06	5.37e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP9—ulcerative colitis	6.5e-06	5.33e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	6.5e-06	5.33e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—IL2—ulcerative colitis	6.5e-06	5.33e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL2—ulcerative colitis	6.48e-06	5.31e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NFKB1—ulcerative colitis	6.43e-06	5.28e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD4—ulcerative colitis	6.43e-06	5.27e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.38e-06	5.24e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RELA—ulcerative colitis	6.35e-06	5.21e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—JAK2—ulcerative colitis	6.26e-06	5.14e-05	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL6—ulcerative colitis	6.25e-06	5.12e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	6.13e-06	5.02e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	6.08e-06	4.99e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	6.07e-06	4.98e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	6.03e-06	4.95e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—STAT3—ulcerative colitis	6e-06	4.92e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CALM3—ulcerative colitis	6e-06	4.92e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL8—ulcerative colitis	5.99e-06	4.91e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.97e-06	4.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—IL6—ulcerative colitis	5.97e-06	4.9e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1B—ulcerative colitis	5.94e-06	4.87e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD4—ulcerative colitis	5.94e-06	4.87e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL2—ulcerative colitis	5.92e-06	4.85e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTGS2—ulcerative colitis	5.89e-06	4.83e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARG—ulcerative colitis	5.86e-06	4.8e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CALM3—ulcerative colitis	5.85e-06	4.8e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—ulcerative colitis	5.79e-06	4.75e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—STAT3—ulcerative colitis	5.78e-06	4.74e-05	CbGpPWpGaD
Gefitinib—ERBB3—Disease—IL6—ulcerative colitis	5.77e-06	4.73e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.73e-06	4.7e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL2—ulcerative colitis	5.72e-06	4.69e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ABCB1—ulcerative colitis	5.7e-06	4.67e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	5.63e-06	4.61e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TGFB1—ulcerative colitis	5.56e-06	4.56e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NFKB1—ulcerative colitis	5.54e-06	4.54e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CALM3—ulcerative colitis	5.52e-06	4.52e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.47e-06	4.48e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP9—ulcerative colitis	5.41e-06	4.44e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TGFB1—ulcerative colitis	5.36e-06	4.39e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NFKB1—ulcerative colitis	5.36e-06	4.39e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADCY5—ulcerative colitis	5.32e-06	4.36e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—IL6—ulcerative colitis	5.3e-06	4.35e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—ulcerative colitis	5.27e-06	4.32e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.23e-06	4.29e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL6—ulcerative colitis	5.2e-06	4.26e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCB1—ulcerative colitis	5.2e-06	4.26e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TGFB1—ulcerative colitis	5.07e-06	4.16e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—STAT3—ulcerative colitis	4.98e-06	4.08e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADCY5—ulcerative colitis	4.85e-06	3.97e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—STAT3—ulcerative colitis	4.81e-06	3.95e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	4.66e-06	3.82e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTGS2—ulcerative colitis	4.61e-06	3.78e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—STAT3—ulcerative colitis	4.6e-06	3.77e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—ulcerative colitis	4.58e-06	3.75e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TGFB1—ulcerative colitis	4.46e-06	3.66e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—ulcerative colitis	4.41e-06	3.62e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—JAK2—ulcerative colitis	4.39e-06	3.6e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.35e-06	3.57e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.29e-06	3.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TGFB1—ulcerative colitis	4.26e-06	3.49e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.25e-06	3.49e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RELA—ulcerative colitis	4.25e-06	3.48e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.25e-06	3.48e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	4.2e-06	3.44e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—IL6—ulcerative colitis	4.19e-06	3.44e-05	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—ulcerative colitis	4.17e-06	3.42e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—IL6—ulcerative colitis	4.04e-06	3.31e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	4.01e-06	3.28e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL8—ulcerative colitis	4e-06	3.28e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	4e-06	3.28e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.97e-06	3.25e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARG—ulcerative colitis	3.96e-06	3.25e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL2—ulcerative colitis	3.83e-06	3.14e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—IL6—ulcerative colitis	3.81e-06	3.12e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—ulcerative colitis	3.77e-06	3.09e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—ulcerative colitis	3.67e-06	3.01e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—ulcerative colitis	3.62e-06	2.97e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARG—ulcerative colitis	3.61e-06	2.96e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.61e-06	2.96e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NFKB1—ulcerative colitis	3.58e-06	2.94e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—ulcerative colitis	3.57e-06	2.92e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL6—ulcerative colitis	3.48e-06	2.85e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—IL6—ulcerative colitis	3.36e-06	2.76e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	3.3e-06	2.71e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.24e-06	2.66e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—STAT3—ulcerative colitis	3.22e-06	2.64e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—IL6—ulcerative colitis	3.21e-06	2.63e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARG—ulcerative colitis	3.17e-06	2.6e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTGS2—ulcerative colitis	3.12e-06	2.56e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.98e-06	2.45e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TGFB1—ulcerative colitis	2.98e-06	2.45e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.96e-06	2.43e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—ulcerative colitis	2.92e-06	2.39e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—ulcerative colitis	2.85e-06	2.34e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTGS2—ulcerative colitis	2.84e-06	2.33e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.8e-06	2.3e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—ulcerative colitis	2.68e-06	2.2e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—ulcerative colitis	2.66e-06	2.18e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.62e-06	2.15e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.55e-06	2.09e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.49e-06	2.04e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—ulcerative colitis	2.46e-06	2.01e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.35e-06	1.93e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.33e-06	1.91e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—IL6—ulcerative colitis	2.25e-06	1.84e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.95e-06	1.6e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.75e-06	1.44e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.53e-06	1.26e-05	CbGpPWpGaD
